Research programme: palmitoyl-protein thioesterase inhibitors - Pinpoint Therapeutics
Alternative Names: Autophagy inhibitors - Pinpoint TherapeuticsLatest Information Update: 28 Mar 2024
At a glance
- Originator Pinpoint Therapeutics
- Class Antineoplastics
- Mechanism of Action Autophagy inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer